logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10738112 B1

PDFFull Text
Date of Patent:
Aug. 11, 2020

Filed:

Jun. 09, 2017

Anti-human interleukin-17a monoclonal antibody

Applicant:

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Shanghai, CN;

Inventors:

Chenghai Zhang, Shanghai, CN;

Lingqiao Zhu, Shanghai, CN;

Jinlin Guo, Shanghai, CN;

Jie Zhao, Shanghai, CN;

Honghai Gao, Shanghai, CN;

Lin Ma, Shanghai, CN;

Wei Dang, Shanghai, CN;

Yan Yang, Shanghai, CN;

Assignee:

SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD., Shanghai, CN;

Attorney:

Greer, Burns & Crain, Ltd.

Primary Examiner:

Dong Jiang

Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61P 17/00 (2006.01); A61P 25/00 (2006.01); A61P 17/06 (2006.01); A61P 27/02 (2006.01); A61P 37/02 (2006.01); A61P 29/00 (2006.01); A61P 19/02 (2006.01); A61P 11/06 (2006.01); A61P 19/08 (2006.01); A61P 37/06 (2006.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/395 (2013.01); A61P 11/06 (2018.01); A61P 17/00 (2018.01); A61P 17/06 (2018.01); A61P 19/02 (2018.01); A61P 19/08 (2018.01); A61P 25/00 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61P 37/02 (2018.01); A61P 37/06 (2018.01); C07K 16/24 (2013.01); C12N 15/85 (2013.01); A61K 38/00 (2013.01); C07K 2317/51 (2013.01); C07K 2317/565 (2013.01); C12N 2015/8518 (2013.01);
Abstract

An anti-human IL-17A monoclonal antibody, the preparation method, and the use thereof are provided. The anti-human IL-17A monoclonal antibody can specifically bind to human IL-17A and has a good effect for inhibiting the secretion of inflammatory cytokines, such as IL-6 and the like by means of various cell lines induced by IL-17A, and can be used for preparing drugs for treating diseases involving immune-medicated inflammatory responses.

Find Patent Forward Citations

Loading…